L’Oreal says it’s working on a form of bioprinted skin that can actually ‘feel’

L’Oreal says it’s working on a form of bioprinted skin that can actually ‘feel’


L’Oreal says it is working with start-ups and research institutions to bioprint skin that can actually “feel.”

L’Oreal

PARIS, France — French beauty and cosmetics giant L’Oreal is working on a form of synthetically produced skin that it says will one day be able to “feel” like we do.

At the Viva Technology conference in Paris last week, L’Oreal showed off demonstrations of “bioprinting,” technology that can 3D print humanlike skin, in action.

The firm has been using this tech for several years to test new makeups on synthetic skin in its lab rather than animals.

L’Oreal says it ceased testing its products on animals back in 1989, long before it was required by regulation.

Guive Balooch, head of L’Oreal’s tech incubator, describes bioprinting as the “ability to use 3D printing with biology to reconstruct skin in personalized ways adjusting for a fully inclusive set of actual reconstructed skin.”

“This is going to be a revolution, too. We’re doing it internally but also working with external partners as well,” Balooch told CNBC at the firm’s booth at VivaTech.

Orange CEO: AI should reflect different global cultures

This skin technology enables L’Oreal to mimic the diversity of real, human skin, including conditions such as eczema and acne, as well as the ability to tan and heal from injury, L’Oreal said in a statement last week.

L’Oréal isn’t just stopping there, though. The company said it’s also working with startups and research institutions to further develop its bioprinting technology to enable skin that can actually “feel.”

“We will have this kind of idea where sensors will allow us to not only have the ability to test on reconstructed skin but also have the … sensory reality feedback, which is what happens when you apply products and all that, so that we can get assessment of not only the efficacy but also the sensory feedback,” Balooch said.

AI assistant for beauty tips

As well as investing into dermatological tech, L’Oreal also showed off innovations around artificial intelligence at France’s massive tech show last week.

At its booth, the company demonstrated an AI-powered beauty assistant called “BeautyGenius.” The app scans a user’s face to identify their facial features.

It then provides the user with a facial analysis, followed by recommendations of products that suit their skin best. It is powered by generative AI, the same technology that powers OpenAI’s ChatGPT chatbot.

L’Oreal also unveiled an AI marketing lab called CREAITECH, which includes tools that allow it to create brand-compliant, AI-generated marketing content.

L’Oreal is incorporating AI-assisted marketing across its 37 beauty brands, which include Kiehl’s, Lancome, and Giorgio Armani Beauty, and Yves Saint Laurent Beauté, according to the firm.



Source

UnitedHealth Group commits to improvements after independent audit, patient backlash
Health

UnitedHealth Group commits to improvements after independent audit, patient backlash

UnitedHealthcare sign is displayed at its office building in Minnetonka, Minnesota, U.S., Dec. 11, 2025. Tim Evans | Reuters UnitedHealth Group on Friday released the first results from a sprawling independent audit of its business practices and committed to a wide range of steps to track and implement improvements in three specific areas. The health-care […]

Read More
Trump signs executive order reclassifying cannabis, opening door to broader weed access
Health

Trump signs executive order reclassifying cannabis, opening door to broader weed access

U.S. President Donald Trump sits in the Oval Office to sign executive orders, at the White House in Washington, D.C., U.S., Dec. 18, 2025. Evelyn Hockstein | Reuters President Donald Trump signed an executive order Thursday directing federal agencies to reclassify marijuana, loosening long-standing restrictions on the drug and marking the most consequential shift in […]

Read More
Eli Lilly says obesity pill helps maintain weight loss after patients switch from Wegovy, Zepbound 
Health

Eli Lilly says obesity pill helps maintain weight loss after patients switch from Wegovy, Zepbound 

Eli Lilly on Thursday said its closely watched obesity pill helped patients maintain the majority of their weight loss after they switched directly from taking the company’s injection Zepbound and Novo Nordisk’s rival shot Wegovy in a late-stage trial.  The company also said it has filed for Food and Drug Administration approval of the daily […]

Read More